Skip to content

To evaluate efficacy of saindhavadi siddha dugdha ashchyotan in vataj abhishyanda (simple allergic conjuctivitis)

An open randomized control clinical trial of saindhavadi siddha dugdha ashchyotan in management of vataj abhishyanda with special reference to simple allergic conjuctivitis - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/12/098695
Enrollment
84
Registered
2025-12-09
Start date
Unknown
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H101- Acute atopic conjunctivitis

Interventions

None listed

Sponsors

Pranjal Arun Salve
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1)Patient show symptoms of allergic conjuctivitis 2)Patient with age above 18 years 3)Patient irrespective of gender , educational socioeconomic ,marital and caste status

Exclusion criteria

Exclusion criteria: 1)Any other active acute infective ocular diseases 2)Recently operated eye within 1 month 3)Patient having systemic disease like DM,CA

Design outcomes

Primary

MeasureTime frame
Redness of eyes,watery mucus, stringy discharge, burning sensation , oedema of eyelids , photophobia , intence itching will be decreased and relief from simple allergic conjuctivitis .Timepoint: 2 weeks

Secondary

MeasureTime frame
to study adverse effect of sandhavadi siddha dugdha aschotan in vataj abhishyanda with special reference to simple allergic conjuctivitisTimepoint: 15 days

Countries

India

Contacts

Public ContactDr pournima Vilas Fasale

Hon Shri Annasaheb Dange Ayurved Medical College Post Graduate And Research Center

pournimafasale33@gmail.com9970177583

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026